Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 25;12(3):925.
doi: 10.3390/jcm12030925.

Prevalence of Overweight and Obesity in France: The 2020 Obepi-Roche Study by the "Ligue Contre l'Obésité"

Affiliations

Prevalence of Overweight and Obesity in France: The 2020 Obepi-Roche Study by the "Ligue Contre l'Obésité"

Annick Fontbonne et al. J Clin Med. .

Abstract

Obepi-Roche 2020 by the "Ligue Contre l'Obésité" (League Against Obesity) estimated overweight and obesity prevalence in France. The adopted methodology was chosen to be as similar as possible to that of a series of quota-based surveys conducted every three years from 1997 to 2012 (Obepi-Roche studies). The 2020 survey was conducted online from 24th September to 5th October 2020 by the Odoxa polling institute on a sample of metropolitan French subjects aged 18 years or over. Participants (n = 9598) self-measured their height and weight according to detailed instructions. Prevalence estimates were produced for all categories of body mass index. The prevalence of excess weight was 47.3% (17.0% of subjects with obesity), with higher values in the north and east of France. When comparing these 2020 estimates to previous Obepi-Roche estimates in order to visualize trends since 1997, it appeared that overweight fluctuated around 30%, and obesity prevalence increased steadily at a rapid pace. The increase was even steeper in the youngest age groups and for severe and complex obesity. Given the slightly different methodologies between the 1997-2012 studies and the 2020 survey, the worrying trends in obesity prevalence since 1997 must be confirmed, calling for a reedition of the Obepi-Roche series.

Keywords: France; obesity; overweight; prevalence.

PubMed Disclaimer

Conflict of interest statement

A.F., P.T., O.F. and D.N. are members of the Scientific Council of the “Ligue Contre l’Obésité” (League Against Obesity), which commissioned and funded the Obepi-Roche 2020 survey. There are no other conflict of interest in relation to this paper.

Figures

Figure 1
Figure 1
Distribution of subjects by BMI category, LCO 2020 Obepi-Roche study.
Figure 2
Figure 2
Regional distribution of the prevalence of obesity (BMI ≥ 30 kg/m2), LCO 2020 Obepi-Roche study.
Figure 3
Figure 3
Position of LCO 2020 Obepi-Roche estimates of overweight and/or obesity compared to the Obepi studies 1997–2012 [8]. Overweight: 25 kg/m2 ≤ BMI < 30 kg/m2; obesity: BMI ≥ 30 kg/m2; severe and complex (“morbid”) obesity: BMI ≥ 40 kg/m2.
Figure 4
Figure 4
Evolution of the prevalence of obesity (BMI ≥ 30 kg/m2) by age groups, Obepi-Roche 1997–2012 [8] with addition of LCO 2020 Obepi-Roche study.
Figure 5
Figure 5
Evolution of the prevalence of obesity (BMI ≥ 30 kg/m2) by professional category, Obepi-Roche 1997–2012 [8] with addition of LCO 2020 Obepi-Roche study.

References

    1. Swinburn B.A., Kraak V.I., Allender S., Atkins V.J., Baker P.I., Bogard J.R., Brinsden H., Calvillo A., De Schutter O., Devarajan R., et al. The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission report. Lancet. 2019;393:791–846. doi: 10.1016/S0140-6736(18)32822-8. - DOI - PubMed
    1. Popkin B.M., Adair L.S., Ng S.W. Global nutrition transition and the pandemic of obesity in developing countries. Nutr. Rev. 2012;70:3–21. doi: 10.1111/j.1753-4887.2011.00456.x. - DOI - PMC - PubMed
    1. World Health Organization . WHO European Regional Obesity Report 2022. WHO Regional Office for Europe; Copenhagen, Denmark: 2022.
    1. Caussy C., Pattou F., Wallet F., Simon C., Chalopin S., Telliam C., Mathieu D., Subtil F., Frobert E., Alligier M., et al. Prevalence of obesity among adult inpatients with COVID-19 in France. Lancet Diabetes Endocrinol. 2020;8:562–564. doi: 10.1016/S2213-8587(20)30160-1. - DOI - PMC - PubMed
    1. Gao M., Piernas C., Astbury N.M., Hippisley-Cox J., O’Rahilly S., Aveyard P., Jebb S.A. Associations between body-mass index and COVID-19 severity in 6.9 million people in England: A prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9:350–359. doi: 10.1016/S2213-8587(21)00089-9. - DOI - PMC - PubMed

LinkOut - more resources